These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3488194)
21. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905 [TBL] [Abstract][Full Text] [Related]
22. [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications]. Chaïbi EB; Mugnier P; Kitzis MD; Goldstein FW; Acar JF Res Microbiol; 1995; 146(9):761-71. PubMed ID: 8584798 [TBL] [Abstract][Full Text] [Related]
23. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections. Calder MA; Croughan MJ; McLeod DT; Ahmad F Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189 [TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis. Renkonen OV Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222 [TBL] [Abstract][Full Text] [Related]
25. Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays. Doern GV; Tubert TA J Clin Microbiol; 1987 Aug; 25(8):1380-3. PubMed ID: 3497942 [TBL] [Abstract][Full Text] [Related]
26. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections. Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201 [TBL] [Abstract][Full Text] [Related]
28. The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis. Farmer TH; Reading C J Antimicrob Chemother; 1988 Aug; 22(2):105-11. PubMed ID: 3263350 [TBL] [Abstract][Full Text] [Related]
29. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae. Cullmann W; Flensberg T; Opferkuch W; Stieglitz M; Wiedemann B Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422 [TBL] [Abstract][Full Text] [Related]
30. A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases. Steingrube VA; Wallace RJ; Beaulieu D J Antimicrob Chemother; 1993 Feb; 31(2):237-44. PubMed ID: 8463169 [TBL] [Abstract][Full Text] [Related]
31. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola]. Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122 [TBL] [Abstract][Full Text] [Related]
32. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains]. Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660 [TBL] [Abstract][Full Text] [Related]
33. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis. Eliasson I; Kamme C Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190 [TBL] [Abstract][Full Text] [Related]
34. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture. Robinson A; Johnson PC; Griffith SB Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321 [TBL] [Abstract][Full Text] [Related]
35. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan. Ikeda F; Yokota Y; Mine Y; Yamada T Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251 [TBL] [Abstract][Full Text] [Related]
36. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998. Mikucka A; Janicka G; Krawiecka D; Kochanowska J Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326 [TBL] [Abstract][Full Text] [Related]
37. Inducible beta-lactamases are principally responsible for the naturally occurring resistance towards beta-lactam antibiotics in Proteus vulgaris. Aspiotis A; Cullmann W; Dick W; Stieglitz M Chemotherapy; 1986; 32(3):236-46. PubMed ID: 3519112 [TBL] [Abstract][Full Text] [Related]
38. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria]. Grimm H Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722 [TBL] [Abstract][Full Text] [Related]
39. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens. Pal RB; Pal P; Jain S; Kulkarni KP J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519 [TBL] [Abstract][Full Text] [Related]
40. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]